-
170.314(a)(3) DEMOGRAPHICS
-
170.314(a)(4) VITAL SIGNS, BODY MASS INDEX, AND GROWTH CHARTS
-
170.314(a)(5) PROBLEM LIST
-
170.314(a)(6) MEDICATION LIST
-
170.314(a)(7) MEDICATION ALLERGY LIST
-
170.314(a)(8) CLINICAL DECISION SUPPORT
-
170.314(a)(9) ELECTRONIC NOTES
-
170.314(a)(10) DRUG-FORMULARY CHECKS
-
170.314(a)(11) SMOKING STATUS
-
170.314(a)(12) IMAGE RESULTS
-
170.314(a)(13) FAMILY HEALTH HISTORY
-
170.314(a)(14) PATIENT LIST CREATION
-
170.314(a)(15) PATIENT-SPECIFIC EDUCATION RESOURCES
-
170.314(b)(1) TRANSITIONS OF CARE – RECEIVE, DISPLAY, AND INCORPORATE TRANSITION OF CARE/REFERRAL SUMMARIES
-
170.314(b)(2) TRANSITIONS OF CARE – CREATE AND TRANSMIT TRANSITION OF CARE/REFERRAL SUMMARIES
-
170.314(b)(3) ELECTRONIC PRESCRIBING
-
170.314(b)(4) CLINICAL INFORMATION RECONCILIATION
-
170.314(b)(5) INCORPORATE LABORATORY TESTS AND VALUES/RESULTS
-
170.314(b)(7) DATA PORTABILITY
-
170.314(c)(1) CLINICAL QUALITY MEASURES – CAPTURE AND EXPORT
-
170.314(c)(2) CLINICAL QUALITY MEASURES – IMPORT AND CALCULATE
-
170.314(c)(3) CLINICAL QUALITY MEASURES – ELECTRONIC SUBMISSION
-
170.314(d)(1) AUTHENTICATION, ACCESS CONTROL, AND AUTHORIZATION
-
170.314(d)(2) AUDITABLE EVENTS AND TAMPER-RESISTANCE
-
170.314(d)(3) AUDIT REPORT(S)
-
170.314(d)(4) AMENDMENTS
-
170.314(d)(5) AUTOMATIC LOG-OFF
-
170.314(d)(6) EMERGENCY ACCESS
-
170.314(d)(7) END-USER DEVICE ENCRYPTION
-
170.314(d)(8) INTEGRITY
-
170.314(e)(1) VIEW, DOWNLOAD, AND TRANSMIT TO 3RD PARTY
-
170.314(e)(2) CLINICAL SUMMARY
-
170.314(e)(3) SECURE MESSAGING
-
170.314(f)(1) IMMUNIZATION INFORMATION
-
170.314(f)(2) TRANSMISSION TO IMMUNIZATION REGISTRIES
-
170.314(f)(3) TRANSMISSION TO PUBLIC HEALTH AGENCIES – SYNDROMIC SURVEILLANCE
-
170.314(g)(2) AUTOMATED MEASURE CALCULATION
-
170.314(g)(3) SAFETY-ENHANCED DESIGN
-
170.314(g)(4) QUALITY MANAGEMENT SYSTEM
-
CMS2 PREVENTIVE CARE AND SCREENING: SCREENING FOR CLINICAL DEPRESSION AND FOLLOW-UP PLAN
-
CMS22 PREVENTIVE CARE AND SCREENING: SCREENING FOR HIGH BLOOD PRESSURE AND FOLLOW-UP DOCUMENTED
-
CMS50 CLOSING THE REFERRAL LOOP: RECEIPT OF SPECIALIST REPORT
-
CMS52 HIV/AIDS: PNEUMOCYSTIS JIROVECI PNEUMONIA (PCP) PROPHYLAXIS
-
CMS56 FUNCTIONAL STATUS ASSESSMENT FOR HIP REPLACEMENT
- CMS61 PREVENTIVE CARE AND SCREENING: CHOLESTEROL – FASTING LOW DENSITY LIPOPROTEIN (LDL-C) TEST PERFORMED
- CMS62 HIV/AIDS: MEDICAL VISIT
- CMS64 PREVENTIVE CARE AND SCREENING: RISK- STRATIFIED CHOLESTEROL – FASTING LOW DENSITY LIPOPROTEIN (LDL-C)
- CMS65 HYPERTENSION: IMPROVEMENT IN BLOOD PRESSURE
- CMS66 FUNCTIONAL STATUS ASSESSMENT FOR KNEE REPLACEMENT
- CMS68 DOCUMENTATION OF CURRENT MEDICATIONS IN THE MEDICAL RECORD
- CMS69 PREVENTIVE CARE AND SCREENING: BODY MASS INDEX (BMI) SCREENING AND FOLLOW-UP
- CMS74 PRIMARY CARIES PREVENTION INTERVENTION AS OFFERED BY PRIMARY CARE PROVIDERS, INCLUDING DENTISTS
- CMS75 CHILDREN WHO HAVE DENTAL DECAY OR CAVITIES
- CMS77 HIV/AIDS: RNA CONTROL FOR PATIENTS WITH HIV
- CMS82 MATERNAL DEPRESSION SCREENING
- CMS90 FUNCTIONAL STATUS ASSESSMENT FOR COMPLEX CHRONIC CONDITIONS
- CMS117 CHILDHOOD IMMUNIZATION STATUS
- CMS122 DIABETES: HEMOGLOBIN A1C POOR CONTROL
- CMS123 DIABETES: FOOT EXAM
- CMS124 CERVICAL CANCER SCREENING
- CMS125 BREAST CANCER SCREENING
- CMS126 USE OF APPROPRIATE MEDICATIONS FOR ASTHMA
- CMS127 PNEUMONIA VACCINATION STATUS FOR OLDER ADULTS
- CMS128 ANTI-DEPRESSANT MEDICATION MANAGEMENT
- CMS129 PROSTATE CANCER: AVOIDANCE OF OVERUSE OF BONE SCAN FOR STAGING LOW RISK PROSTATE CANCER PATIENTS
- CMS130 COLORECTAL CANCER SCREENING
- CMS131 DIABETES: EYE EXAM
- CMS132 CATARACTS: COMPLICATIONS WITHIN 30 DAYS FOLLOWING CATARACT SURGERY REQUIRING ADDITIONAL SURGICAL PROCEDURES
- CMS133 CATARACTS: 20/40 OR BETTER VISUAL ACUITY WITHIN 90 DAYS FOLLOWING CATARACT SURGERY
- CMS134 DIABETES: URINE PROTEIN SCREENING
- CMS135 HEART FAILURE (HF): ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITOR OR ANGIOTENSIN RECEPTOR BLOCKER (ARB) THERAPY FOR LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (LVSD)
- CMS136 ADHD: FOLLOW-UP CARE FOR CHILDREN PRESCRIBED ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) MEDICATION
- CMS137 INITIATION AND ENGAGEMENT OF ALCOHOL AND OTHER DRUG DEPENDENCE TREATMENT
- CMS138 PREVENTIVE CARE AND SCREENING: TOBACCO USE: SCREENING AND CESSATION INTERVENTION
- CMS139 SCREENING FOR FUTURE FALL RISK
- CMS140 BREAST CANCER: HORMONAL THERAPY FOR STAGE IC-IIIC ESTROGEN RECEPTOR/PROGESTERONE RECEPTOR (ER/PR) POSITIVE BREAST CANCER
- CMS141 COLON CANCER: CHEMOTHERAPY FOR AJCC STAGE III COLON CANCER PATIENTS
- CMS142 DIABETIC RETINOPATHY: COMMUNICATION WITH THE PHYSICIAN MANAGING ONGOING DIABETES CARE
- CMS143 PRIMARY OPEN ANGLE GLAUCOMA (POAG): OPTIC NERVE EVALUATION
- CMS144 HEART FAILURE (HF): BETA-BLOCKER THERAPY FOR LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (LVSD)
- CMS145 CORONARY ARTERY DISEASE (CAD): BETA-BLOCKER THERAPY- PRIOR MYOCARDIAL INFARCTION (MI) OR LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (LVEF <40%)
- CMS146 APPROPRIATE TESTING FOR CHILDREN WITH PHARYNGITIS
- CMS147 PREVENTATIVE CARE AND SCREENING: INFLUENZA IMMUNIZATION
- CMS148 HEMOGLOBIN A1C TEST FOR PEDIATRIC PATIENTS
- CMS149 DEMENTIA: COGNITIVE ASSESSMENT
- CMS153 CHLAMYDIA SCREENING FOR WOMEN
- CMS154 APPROPRIATE TREATMENT FOR CHILDREN WITH UPPER RESPIRATORY INFECTION (URI)
- CMS155 WEIGHT ASSESSMENT AND COUNSELING FOR NUTRITION AND PHYSICAL ACTIVITY FOR CHILDREN AND ADOLESCENTS
- CMS156 USE OF HIGH-RISK MEDICATIONS IN THE ELDERLY
- CMS157 ONCOLOGY: MEDICAL AND RADIATION – PAIN INTENSITY QUANTIFIED
- CMS158 PREGNANT WOMEN THAT HAD HBSAG TESTING
- CMS159 DEPRESSION REMISSION AT TWELVE MONTHS
- CMS160 DEPRESSION UTILIZATION OF THE PHQ-9 TOOL
- CMS161 MAJOR DEPRESSIVE DISORDER (MDD): SUICIDE RISK ASSESSMENT
- CMS163 DIABETES: LOW DENSITY LIPOPROTEIN (LDL) MANAGEMENT
- CMS164 ISCHEMIC VASCULAR DISEASE (IVD): USE OF ASPIRIN OR ANOTHER ANTITHROMBOTIC
- CMS165 CONTROLLING HIGH BLOOD PRESSURE
- CMS166 USE OF IMAGING STUDIES FOR LOW BACK PAIN
- CMS167 DIABETIC RETINOPATHY: DOCUMENTATION OF PRESENCE OR ABSENCE OF MACULAR EDEMA AND LEVEL OF SEVERITY OF RETINOPATHY
- CMS169 BIPOLAR DISORDER AND MAJOR DEPRESSION: APPRAISAL FOR ALCOHOL OR CHEMICAL SUBSTANCE USE
- CMS177 CHILD AND ADOLESCENT MAJOR DEPRESSIVE DISORDER: SUICIDE RISK ASSESSMENT
- CMS179 ADE PREVENTION AND MONITORING: WARFARIN TIME IN THERAPEUTIC RANGE.
- CMS182 ISCHEMIC VASCULAR DISEASE (IVD): COMPLETE LIPID PANEL AND LDL CONTROL